Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies

被引：13
|
作者：
Alvarez-Cuesta, CCA
Raya-Aguado, C
Fernández-Rippe, ML
Sánchez, TS
Pérez-Oliva, N
机构：
[1] Univ Oviedo, Hosp Cent Asturias, Dept Dermatol, E-33080 Oviedo, Spain
[2] Univ Oviedo, Hosp Cent Asturias, Dept Internal Med, E-33080 Oviedo, Spain
[3] Univ Oviedo, Hosp Cent Asturias, Dept Pathol, E-33080 Oviedo, Spain
来源：
DERMATOLOGY | 2001年 / 203卷 / 04期
关键词：
anetoderma; lupus; antiphospholipid antibody; anti-proliferating-cell-nuclear-antigen antibody;
D O I：
10.1159/000051789
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Anetoderma is a rare elastolytic disorder included within the group of cutaneous atrophies. Its pathogenesis is not yet clearly established, but immunological mechanisms could play an important role in dermal elastolysis. It has been associated with different autoantibodies and autoimmune disorders. We present a case of anetoderma in a systemic lupus erythematosus patient with anti-proliferating-cell-nuclear-antigen and antiphospholipid antibodies, highlighting the peculiarities of such an association. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码：348 / 350
页数：3
相关论文
共 50 条
  • [1] Anetoderma in systemic lupus erythematosus:: relationship to antiphospholipid antibodies
    Montilla, C
    Alarcón-Segovia, D
    LUPUS, 2000, 9 (07) : 545 - 547
  • [2] Anetoderma associated with antiphospholipid syndrome and systemic lupus erythematosus
    Bilen, N
    Bayramgürler, D
    Sikar, A
    Erçin, C
    Yilmaz, A
    LUPUS, 2003, 12 (09) : 714 - 716
  • [3] Eruptive Anetoderma in a Patient with Systemic Lupus Erythematosus
    Jeong, Nam-Ji
    Park, Seung-Bae
    Im, Myung
    Seo, Young-Joon
    Lee, Jeung-Hoon
    Lee, Young
    ANNALS OF DERMATOLOGY, 2014, 26 (05) : 621 - 623
  • [4] ANTIPHOSPHOLIPID ANTIBODIES IN PEDIATRIC SYSTEMIC LUPUS-ERYTHEMATOSUS
    SEAMAN, DE
    LONDINO, AV
    KWOH, CK
    MEDSGER, TA
    MANZI, S
    PEDIATRICS, 1995, 96 (06) : 1040 - 1045
  • [5] The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
    Unlu, Ozan
    Zuily, Stephane
    Erkan, Doruk
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2016, 3 (02) : 75 - 84
  • [6] Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus
    Ilgen, U.
    Yayla, M. E.
    Ates, A.
    Okatan, I. E.
    Yurteri, E. U.
    Torgutalp, M.
    Kelesoglu, A. B. D.
    Turgay, T. M.
    Kinikli, G.
    LUPUS, 2018, 27 (04) : 665 - 669
  • [7] Antiphospholipid antibodies and osteonecrosis in systemic lupus erythematosus: a meta-analysis
    Qijiao, Wei
    Meng, Zhou
    Jianwen, Liu
    Shengli, Zhang
    Fei, Gao
    He, Lin
    Zhihan, Chen
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (08) : 923 - 932
  • [8] Immunoadsorption plasmapheresis as a treatment for pregnancy complicated by systemic lupus erythematosus with positive antiphospholipid antibodies
    Nakamura, Y
    Yoshida, K
    Itoh, S
    Kanai, Y
    Tsuda, H
    Hashimoto, H
    Mitsuhashi, N
    Kuwabara, Y
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1999, 41 (05) : 307 - 311
  • [9] Circulating osteoprotegerin levels are elevated and correlated with antiphospholipid antibodies in patients with systemic lupus erythematosus
    Kwok, S. K.
    Shin, Y. J.
    Kim, H. J.
    Kim, H. S.
    Kim, J. Y.
    Yoo, S. A.
    Choi, J. J.
    Kim, W. U.
    Cho, C. S.
    LUPUS, 2009, 18 (02) : 133 - 138
  • [10] ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND LABORATORY ASSOCIATIONS IN 111 PATIENTS
    WANG, Y
    SCHRIEBER, L
    COHEN, MG
    FURPHY, L
    WEBB, J
    CHIVERS, T
    POLLARD, KM
    RHEUMATOLOGY INTERNATIONAL, 1990, 10 (02) : 75 - 80
12345